Skip to main content
Top
Published in: AIDS and Behavior 4/2015

01-04-2015 | Original Paper

Explaining Antiretroviral Therapy Adherence Success Among HIV-Infected Children in Rural Uganda: A Qualitative Study

Authors: Peter K. Olds, Julius P. Kiwanuka, Norma C. Ware, Alexander C. Tsai, Jessica E. Haberer

Published in: AIDS and Behavior | Issue 4/2015

Login to get access

Abstract

High adherence is critical for achieving clinical benefits of HIV antiretroviral therapy (ART) and particularly challenging for children. We conducted 35 qualitative interviews with caregivers of HIV-infected Ugandan children who were followed in a longitudinal study of real-time ART adherence monitoring; 18 participants had undetectable HIV RNA, while 17 had detectable virus. Interviews blinded to viral suppression status elicited information on adherence experiences, barriers and facilitators to adherence, and social support. Using an inductive content analytic approach, we identified ‘lack of resources,’ ‘Lazarus effect,’ ‘caregiver’s sense of obligation and commitment,’ and ‘child’s personal responsibility’ as categories of influence on adherence, and defined types of caregiver social support. Among children with viral suppression, high hopes for the child’s future and ready access to private instrumental support appeared particularly important. These findings suggest clinical counseling should explore caregivers’ views of their children’s futures and ability to access support in overcoming adherence barriers.

Resumen

Gran adherencia es fundamental para el logro de los beneficios clínicos de la terapia antirretroviral contra el VIH y es particularmente difícil para los niños. Hemos llevado a cabo 35 entrevistas cualitativas a los cuidadores de los niños Ugandeses infectados por el VIH que fueron seguidos en un estudio longitudinal de la supervisión del adherencia terapéutico antirretroviral en tiempo real; 18 participantes tenían indetectable de ARN del VIH, mientras que 17 tenían virus detectable. Entrevistas sin conocimiento al estado de supresión viral provocaron información sobre las experiencias de adherencia, barreras y facilitadores para la adhesión y el apoyo social. El uso de un enfoque analítico contenido inductivo, hemos identificado ‘falta de recursos’, ‘efecto Lázaro’, ‘sentido del cuidador de la obligación y compromiso’, y ‘la responsabilidad personal del niño’ como las categorías de influencia en la adherencia y tipos definidos de apoyo social del cuidador. Entre los niños con la supresión viral, grandes esperanzas para el futuro acceso y listo del niño para el apoyo instrumental privada parecían especialmente importantes. Estos hallazgos sugieren asesoramiento clínico debe explorar puntos de vista de los cuidadores de futuro de sus hijos y la posibilidad de acceder a la ayuda en la superación de las barreras de adherencia.
Appendix
Available only for authorised users
Literature
1.
go back to reference UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013. Geneva, UNAIDS; 2013. UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013. Geneva, UNAIDS; 2013.
2.
go back to reference WHO. Global update on HIV treatment 2013: Results, impact and opportunities; 2013. WHO. Global update on HIV treatment 2013: Results, impact and opportunities; 2013.
3.
go back to reference Haberer JE, Cook A, Walker AS, et al. Excellent adherence to antiretrovirals in HIV + Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS ONE. 2011;6(4):e18505.CrossRefPubMedCentralPubMed Haberer JE, Cook A, Walker AS, et al. Excellent adherence to antiretrovirals in HIV + Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS ONE. 2011;6(4):e18505.CrossRefPubMedCentralPubMed
4.
go back to reference Barro M, Some J, Foulongne V, et al. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. J Acquir Immune Defic Syndr. 2011;57(Suppl 1):S44–9.CrossRefPubMed Barro M, Some J, Foulongne V, et al. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. J Acquir Immune Defic Syndr. 2011;57(Suppl 1):S44–9.CrossRefPubMed
5.
go back to reference Orrell C, Levison J, Ciaranello A, et al. Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy. Pediatr Infect Dis J. 2013;32(6):644–7.CrossRefPubMed Orrell C, Levison J, Ciaranello A, et al. Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy. Pediatr Infect Dis J. 2013;32(6):644–7.CrossRefPubMed
6.
go back to reference Ahoua L, Guenther G, Rouzioux C, et al. Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda. BMC Pediatr. 2011;11:67.CrossRefPubMedCentralPubMed Ahoua L, Guenther G, Rouzioux C, et al. Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda. BMC Pediatr. 2011;11:67.CrossRefPubMedCentralPubMed
7.
go back to reference Dehority W, Deville JG, Lujan-Zilbermann J, Spector SA, Viani RM. Effect of HIV genotypic drug resistance testing on the management and clinical course of HIV-infected children and adolescents. Int J STD AIDS. 2013;24(7):549–53.CrossRefPubMed Dehority W, Deville JG, Lujan-Zilbermann J, Spector SA, Viani RM. Effect of HIV genotypic drug resistance testing on the management and clinical course of HIV-infected children and adolescents. Int J STD AIDS. 2013;24(7):549–53.CrossRefPubMed
8.
go back to reference Barth RE, Tempelman HA, Smelt E, Wensing AM, Hoepelman AI, Geelen SP. Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment. Pediatr Infect Dis J. 2011;30(1):52–6.CrossRefPubMed Barth RE, Tempelman HA, Smelt E, Wensing AM, Hoepelman AI, Geelen SP. Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment. Pediatr Infect Dis J. 2011;30(1):52–6.CrossRefPubMed
9.
go back to reference Shet A, DeCosta A, Heylen E, Shastri S, Chandy S, Ekstrand M. High rates of adherence and treatment success in a public and public-private HIV clinic in India: potential benefits of standardized national care delivery systems. BMC Health Serv Res. 2011;11:277.CrossRefPubMedCentralPubMed Shet A, DeCosta A, Heylen E, Shastri S, Chandy S, Ekstrand M. High rates of adherence and treatment success in a public and public-private HIV clinic in India: potential benefits of standardized national care delivery systems. BMC Health Serv Res. 2011;11:277.CrossRefPubMedCentralPubMed
11.
go back to reference Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–91.CrossRefPubMed Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–91.CrossRefPubMed
12.
go back to reference Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl). 2013;5:1–17. Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl). 2013;5:1–17.
13.
go back to reference Weiser SD, Palar K, Frongillo EA, et al. Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda. AIDS. 2013;28(1):115–20.CrossRef Weiser SD, Palar K, Frongillo EA, et al. Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda. AIDS. 2013;28(1):115–20.CrossRef
14.
go back to reference Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS ONE. 2012;7(5):e36737.CrossRefPubMedCentralPubMed Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS ONE. 2012;7(5):e36737.CrossRefPubMedCentralPubMed
15.
go back to reference Buchanan AL, Montepiedra G, Sirois PA, et al. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics. 2012;129(5):e1244–51.CrossRefPubMedCentralPubMed Buchanan AL, Montepiedra G, Sirois PA, et al. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics. 2012;129(5):e1244–51.CrossRefPubMedCentralPubMed
16.
go back to reference Fetzer BC, Mupenda B, Lusiama J, Kitetele F, Golin C, Behets F. Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study. AIDS Patient Care STDS. 2011;25(10):611–21.CrossRefPubMed Fetzer BC, Mupenda B, Lusiama J, Kitetele F, Golin C, Behets F. Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study. AIDS Patient Care STDS. 2011;25(10):611–21.CrossRefPubMed
17.
go back to reference Coetzee B, Kagee A, Vermeulen N. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers. AIDS Care. 2011;23(2):146–51.CrossRefPubMed Coetzee B, Kagee A, Vermeulen N. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers. AIDS Care. 2011;23(2):146–51.CrossRefPubMed
18.
go back to reference Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14(4):778–84.CrossRefPubMedCentralPubMed Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14(4):778–84.CrossRefPubMedCentralPubMed
19.
go back to reference Mutwa PR, Van Nuil JI, Asiimwe-Kateera B, et al. Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study. PLoS ONE. 2013;8(4):e60073.CrossRefPubMedCentralPubMed Mutwa PR, Van Nuil JI, Asiimwe-Kateera B, et al. Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study. PLoS ONE. 2013;8(4):e60073.CrossRefPubMedCentralPubMed
20.
go back to reference Malee K, Williams PL, Montepiedra G, et al. The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. J Pediatr Psychol. 2009;34(2):164–75.CrossRefPubMedCentralPubMed Malee K, Williams PL, Montepiedra G, et al. The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. J Pediatr Psychol. 2009;34(2):164–75.CrossRefPubMedCentralPubMed
21.
go back to reference Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 Suppl 2):18640.PubMedCentralPubMed Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 Suppl 2):18640.PubMedCentralPubMed
22.
go back to reference Lankowski AJ, Siedner MJ, Bangsberg DR, Tsai AC. Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav. 2014;18(7):1199–223.CrossRefPubMed Lankowski AJ, Siedner MJ, Bangsberg DR, Tsai AC. Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav. 2014;18(7):1199–223.CrossRefPubMed
23.
go back to reference Siedner MJ, Lankowski A, Tsai AC, et al. GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS. 2013;27(9):1503–8.CrossRefPubMedCentralPubMed Siedner MJ, Lankowski A, Tsai AC, et al. GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS. 2013;27(9):1503–8.CrossRefPubMedCentralPubMed
24.
go back to reference Tsai AC, Bangsberg DR. The importance of social ties in sustaining medication adherence in resource-limited settings. J Gen Intern Med. 2011;26(12):1391–3.CrossRefPubMedCentralPubMed Tsai AC, Bangsberg DR. The importance of social ties in sustaining medication adherence in resource-limited settings. J Gen Intern Med. 2011;26(12):1391–3.CrossRefPubMedCentralPubMed
25.
go back to reference Boivin MJ, Bangirana P, Nakasujja N, et al. A year-long caregiver training program improves cognition in preschool Ugandan children with human immunodeficiency virus. J Pediatr. 2013;163(5):1409–19.CrossRefPubMed Boivin MJ, Bangirana P, Nakasujja N, et al. A year-long caregiver training program improves cognition in preschool Ugandan children with human immunodeficiency virus. J Pediatr. 2013;163(5):1409–19.CrossRefPubMed
26.
go back to reference Boivin MJ, Bangirana P, Nakasujja N, et al. A year-long caregiver training program to improve neurocognition in preschool Ugandan HIV-exposed children. J Dev Behav Pediatr. 2013;34(4):269–78.CrossRefPubMedCentralPubMed Boivin MJ, Bangirana P, Nakasujja N, et al. A year-long caregiver training program to improve neurocognition in preschool Ugandan HIV-exposed children. J Dev Behav Pediatr. 2013;34(4):269–78.CrossRefPubMedCentralPubMed
27.
go back to reference Nelson CA 3rd, Zeanah CH, Fox NA, Marshall PJ, Smyke AT, Guthrie D. Cognitive recovery in socially deprived young children: the Bucharest Early Intervention project. Science. 2007;318(5858):1937–40.CrossRefPubMed Nelson CA 3rd, Zeanah CH, Fox NA, Marshall PJ, Smyke AT, Guthrie D. Cognitive recovery in socially deprived young children: the Bucharest Early Intervention project. Science. 2007;318(5858):1937–40.CrossRefPubMed
28.
go back to reference Venkataramani AS. Early life exposure to malaria and cognition in adulthood: evidence from Mexico. J Health Econ. 2012;31(5):767–80.CrossRefPubMed Venkataramani AS. Early life exposure to malaria and cognition in adulthood: evidence from Mexico. J Health Econ. 2012;31(5):767–80.CrossRefPubMed
29.
go back to reference Heckman JJ. Skill formation and the economics of investing in disadvantaged children. Science. 2006;312(5782):1900–2.CrossRefPubMed Heckman JJ. Skill formation and the economics of investing in disadvantaged children. Science. 2006;312(5782):1900–2.CrossRefPubMed
30.
go back to reference Heckman JJ, Masterov DV. The productivity argument for investing in young children. Rev Agric Econ. 2007;29(3):446–93.CrossRef Heckman JJ, Masterov DV. The productivity argument for investing in young children. Rev Agric Econ. 2007;29(3):446–93.CrossRef
31.
go back to reference Talisuna-Alamo S, Colebunders R, Ouma J, et al. Socioeconomic support reduces nonretention in a comprehensive, community-based antiretroviral therapy program in Uganda. J Acquir Immune Defic Syndr. 2012;59(4):e52–9.CrossRefPubMed Talisuna-Alamo S, Colebunders R, Ouma J, et al. Socioeconomic support reduces nonretention in a comprehensive, community-based antiretroviral therapy program in Uganda. J Acquir Immune Defic Syndr. 2012;59(4):e52–9.CrossRefPubMed
32.
go back to reference Cohen S, McKay G. Social support, stress and the buffering hypothesis: a theoretical analysis. In: Baum A, Taylor SE, Singer JE, editors. Handbook of psychology and health: social psychological aspects of health. Hillsdale: N.J. :L. Erlbaum Associates; 1984. p. 253–267. Cohen S, McKay G. Social support, stress and the buffering hypothesis: a theoretical analysis. In: Baum A, Taylor SE, Singer JE, editors. Handbook of psychology and health: social psychological aspects of health. Hillsdale: N.J. :L. Erlbaum Associates; 1984. p. 253–267.
33.
go back to reference Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985;98(2):310–57.CrossRefPubMed Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985;98(2):310–57.CrossRefPubMed
34.
go back to reference Cassel J. The contribution of the social environment to host resistance: the Fourth Wade Hampton Frost Lecture. Am J Epidemiol. 1976;104(2):107–23.PubMed Cassel J. The contribution of the social environment to host resistance: the Fourth Wade Hampton Frost Lecture. Am J Epidemiol. 1976;104(2):107–23.PubMed
35.
go back to reference Dean A, Lin N. The stress-buffering role of social support. Problems and prospects for systematic investigation. J Nerv Ment Dis. 1977;165(6):403–17.CrossRefPubMed Dean A, Lin N. The stress-buffering role of social support. Problems and prospects for systematic investigation. J Nerv Ment Dis. 1977;165(6):403–17.CrossRefPubMed
36.
go back to reference Russell S, Seeley J, Ezati E, Wamai N, Were W, Bunnell R. Coming back from the dead: living with HIV as a chronic condition in rural Africa. Health Policy Plan. 2007;22(5):344–7.CrossRefPubMed Russell S, Seeley J, Ezati E, Wamai N, Were W, Bunnell R. Coming back from the dead: living with HIV as a chronic condition in rural Africa. Health Policy Plan. 2007;22(5):344–7.CrossRefPubMed
37.
go back to reference Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.CrossRefPubMed Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.CrossRefPubMed
38.
go back to reference Haberer JE, Kiwanuka J, Nansera D, et al. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS. 2013;27(13):2166–8. Haberer JE, Kiwanuka J, Nansera D, et al. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS. 2013;27(13):2166–8.
39.
go back to reference Haberer J. Novel measures and theory of pediatric antiretroviral therapy adherence in Uganda. Mbarara: Massachusetts General Hospital; 2010. Haberer J. Novel measures and theory of pediatric antiretroviral therapy adherence in Uganda. Mbarara: Massachusetts General Hospital; 2010.
40.
go back to reference Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010;14(6):1294–301.CrossRefPubMedCentralPubMed Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010;14(6):1294–301.CrossRefPubMedCentralPubMed
42.
go back to reference Havlir DV, Bassett R, Levitan D, et al. Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA. 2001;286(2):171–9.CrossRefPubMed Havlir DV, Bassett R, Levitan D, et al. Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA. 2001;286(2):171–9.CrossRefPubMed
43.
go back to reference Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRefPubMed Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRefPubMed
44.
go back to reference Leland J. The end of AIDS? Newsweek. 1996;128(23):64-68, 71, 73. Leland J. The end of AIDS? Newsweek. 1996;128(23):64-68, 71, 73.
45.
go back to reference Nagata JM, Magerenge RO, Young SL, Oguta JO, Weiser SD, Cohen CR. Social determinants, lived experiences, and consequences of household food insecurity among persons living with HIV/AIDS on the shore of Lake Victoria, Kenya. AIDS Care. 2012;24(6):728–36.CrossRefPubMed Nagata JM, Magerenge RO, Young SL, Oguta JO, Weiser SD, Cohen CR. Social determinants, lived experiences, and consequences of household food insecurity among persons living with HIV/AIDS on the shore of Lake Victoria, Kenya. AIDS Care. 2012;24(6):728–36.CrossRefPubMed
46.
go back to reference Anabwani G, Navario P. Nutrition and HIV/AIDS in sub-Saharan Africa: an overview. Nutrition. 2005;21(1):96–9.CrossRefPubMed Anabwani G, Navario P. Nutrition and HIV/AIDS in sub-Saharan Africa: an overview. Nutrition. 2005;21(1):96–9.CrossRefPubMed
47.
go back to reference Glanz K, Rimer BK, Viswanath K. Health behavior and health education : theory, research, and practice. 4th ed. San Francisco: Jossey-Bass; 2008. Glanz K, Rimer BK, Viswanath K. Health behavior and health education : theory, research, and practice. 4th ed. San Francisco: Jossey-Bass; 2008.
48.
go back to reference Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(11):1035–41.CrossRefPubMed Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(11):1035–41.CrossRefPubMed
49.
50.
go back to reference Tsai AC, Bangsberg DR, Frongillo EA, et al. Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. Soc Sci Med. 2012;74(12):2012–9.CrossRefPubMedCentralPubMed Tsai AC, Bangsberg DR, Frongillo EA, et al. Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. Soc Sci Med. 2012;74(12):2012–9.CrossRefPubMedCentralPubMed
51.
go back to reference Davies B, Whitsett SF, Bruce A, McCarthy P. A typology of fatigue in children with cancer. J Pediatr Oncol Nurs. 2002;19(1):12–21.CrossRefPubMed Davies B, Whitsett SF, Bruce A, McCarthy P. A typology of fatigue in children with cancer. J Pediatr Oncol Nurs. 2002;19(1):12–21.CrossRefPubMed
52.
go back to reference Foster SD, Nakamanya S, Kyomuhangi R, et al. The experience of “medicine companions” to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. AIDS Care. 2010;22(Suppl 1):35–43.CrossRefPubMedCentralPubMed Foster SD, Nakamanya S, Kyomuhangi R, et al. The experience of “medicine companions” to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. AIDS Care. 2010;22(Suppl 1):35–43.CrossRefPubMedCentralPubMed
53.
go back to reference Vreeman RC, Gramelspacher AM, Gisore PO, Scanlon ML, Nyandiko WM. Disclosure of HIV status to children in resource-limited settings: a systematic review. J Int AIDS Soc. 2013;16:18466.CrossRefPubMedCentralPubMed Vreeman RC, Gramelspacher AM, Gisore PO, Scanlon ML, Nyandiko WM. Disclosure of HIV status to children in resource-limited settings: a systematic review. J Int AIDS Soc. 2013;16:18466.CrossRefPubMedCentralPubMed
54.
go back to reference WHO. Guidline on HIV Disclosure Counselling for Children up to 12 Years of Age: WHO;2011. WHO. Guidline on HIV Disclosure Counselling for Children up to 12 Years of Age: WHO;2011.
56.
go back to reference Tsai AC, Bangsberg DR, Kegeles SM, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013;46(3):285–94.CrossRefPubMed Tsai AC, Bangsberg DR, Kegeles SM, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013;46(3):285–94.CrossRefPubMed
58.
go back to reference Kalichman SC, et al. The harms of internalized AIDS stigma: a comment on Tsai.et.al. Ann Behav Med. 2013;46(3):256–7.CrossRefPubMed Kalichman SC, et al. The harms of internalized AIDS stigma: a comment on Tsai.et.al. Ann Behav Med. 2013;46(3):256–7.CrossRefPubMed
59.
go back to reference MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav. 2013;17(1):86–93.CrossRefPubMedCentralPubMed MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav. 2013;17(1):86–93.CrossRefPubMedCentralPubMed
60.
go back to reference Zurovac D, Otieno G, Kigen S, et al. Ownership and use of mobile phones among health workers, caregivers of sick children and adult patients in Kenya: cross-sectional national survey. Global Health. 2013;9:20.CrossRefPubMedCentralPubMed Zurovac D, Otieno G, Kigen S, et al. Ownership and use of mobile phones among health workers, caregivers of sick children and adult patients in Kenya: cross-sectional national survey. Global Health. 2013;9:20.CrossRefPubMedCentralPubMed
Metadata
Title
Explaining Antiretroviral Therapy Adherence Success Among HIV-Infected Children in Rural Uganda: A Qualitative Study
Authors
Peter K. Olds
Julius P. Kiwanuka
Norma C. Ware
Alexander C. Tsai
Jessica E. Haberer
Publication date
01-04-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0924-7

Other articles of this Issue 4/2015

AIDS and Behavior 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine